Live symbol workspace

CVS market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $73.51

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$69.83

Resistance

$77.19

Volume & Momentum

Volume

Weak

0.8x avg

Momentum

0%

Weak

Technical Context

Current price

$73.51

RSI context

50

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

30%

— 0.0 pts vs previous week

Avg confidence across 44 calls in the last 7 days

What sources say

Neutral 2 articles

Healthy Returns: Walmart, CVS step in to help seniors navigate Medicare coverage of obesity drugs

Why CVS Stock Trounced the Market Today

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

CVS News Intelligence (19 articles)

AI-curated news influencing CVS price, sentiment, and trend

Explore All CVS News with AI Analysis

Economy

1 month, 2 weeks ago

How Safe Is CVS Health's Dividend?

Investors shouldn't lose sleep over the possibility that the dividend is in danger.

Impact on CVS: Neutral market sentiment indicated

Financial market analysis indicating neutral sentiment based on current trends. Medium (50%)

View full analysis →

Yahoo Finance 50% confidence

Stocks

1 month, 2 weeks ago

Lilly’s GLP-1 medications will soon be covered by CVS, potentially opening access for millions of Americans

That means millions more Americans may get access to Lilly’s new GLP-1 pill Foundayo or the GLP-1 injection Zepbound.

Impact on CVS: Neutral market sentiment indicated

Financial market analysis indicating neutral sentiment based on current trends. Medium (50%)

View full analysis →

MarketWatch 50% confidence

Technology

1 month, 2 weeks ago

H1 secures $40M from CVS, proving SaaS startups can still attract investment

CEO Ariel Katz argues that while AI can replicate workflow SaaS, it can't copy H1’s unique doctor data.

Impact on CVS: Neutral market sentiment indicated

Financial market analysis indicating neutral sentiment based on current trends. Medium (50%)

View full analysis →

TechCrunch 50% confidence

Stocks

1 month, 2 weeks ago

CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans

CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.

Impact on CVS: Neutral market sentiment indicated

Financial market analysis indicating neutral sentiment based on current trends. Medium (50%)

View full analysis →

CNBC 50% confidence

Economy

2 months ago

CVS Health Stock Hits a New 52-Week High After Posting Strong Q1 Results. Here's Why It Can Still Go Even Higher

The healthcare giant's stock is up after it posted another solid quarter, which showed a big improvement in its bottom …

Impact on CVS: Potentially positive price action expected

Analysis of stock market developments showing bullish sentiment. Medium (60%)

View full analysis →

Yahoo Finance 60% confidence

Economy ⭐ FEATURED

2 months, 1 week ago

CVS Results Beat, Extending Healthcare Win Streak

CVS raised its earnings outlook for the year after profit and revenue in the first quarter exceeded analyst expectations, the …

Impact on CVS: Potentially positive price action expected

Financial market analysis indicating bullish sentiment based on current trends. High (70%)

View full analysis →

Bloomberg 70% confidence